Screener
Asset Entities ASST Medical Device — Other income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Total investment losses | (236,794) | — |
| Net operating loss | (258,249) | (3,690) |
| Other income/(expense): | ||
| Other income | 955 | 252 |
| Interest expense on long-term notes payable, at fair value | (40) | — |
| Change in fair value on long-term notes payable, at fair value | (299) | — |
| Gain on extinguishment of debt | 30 | — |
| Transaction costs | — | (5,437) |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — other income?
- Asset Entities (ASST) reported medical device — other income of $270K in Q2 2026.
- What does medical device — other income mean?
- Represents secondary revenue streams generated by the medical device business segment that fall outside of primary product sales or service fees. This metric helps investors identify ancillary income sources that contribute to the segment's overall financial performance.
Ask your AI about Asset Entities's medical device — other income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude